Human Glutamate Decarboxylase 2 (GAD2) CLIA Kit
Human Glutamate Decarboxylase 2 (GAD2) Chemiluminescent Immunoassay (CLIA) Kit is a Chemiluminescent Immunoassay (CLIA) kit against Glutamate Decarboxylase 2 (GAD2). This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein.
Supplier | Abbexa Ltd. |
---|---|
Product # | abx197021-96T |
Pricing | 96 tests USD $717.75 |
Tested Applications | CLIA |
Test Range | 0.156 ng/ml - 10 ng/ml |
UniProt Primary AC | Q05329 |
Availability | Shipped within 5-12 working days. |
Dry Ice | No |
Note |
|